Form 8-K - Current report:
SEC Accession No. 0001213900-26-078019
Filing Date
2026-07-14
Accepted
2026-07-14 17:19:56
Documents
13
Period of Report
2026-07-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0297987-8k_longeveron.htm   iXBRL 8-K 32833
2 REVISED LETTER AGREEMENT, DATED JULY 8, 2026 ea029798701ex10-1.htm EX-10.1 55633
3 GRAPHIC ea029798701_ex10-1img1.jpg GRAPHIC 4712
  Complete submission text file 0001213900-26-078019.txt   281343

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE lgvn-20260708.xsd EX-101.SCH 3020
5 XBRL LABEL FILE lgvn-20260708_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE lgvn-20260708_pre.xml EX-101.PRE 22362
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0297987-8k_longeveron_htm.xml XML 3322
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 261175055
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)